1. Home
  2. BOXL vs GOVX Comparison

BOXL vs GOVX Comparison

Compare BOXL & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boxlight Corporation

BOXL

Boxlight Corporation

N/A

Current Price

$2.61

Market Cap

3.1M

ML Signal

N/A

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

N/A

Current Price

$0.17

Market Cap

3.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BOXL
GOVX
Founded
1985
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
3.0M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
BOXL
GOVX
Price
$2.61
$0.17
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
26.8K
★ 96.5K
Earning Date
11-09-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $25,743,612.00
$2,489,145.00
Revenue This Year
$0.69
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 26.37
N/A
52 Week Low
$2.35
$0.18
52 Week High
$54.72
$1,434.75

Technical Indicators

Market Signals
Indicator
BOXL
GOVX
Relative Strength Index (RSI) 28.40 8.98
Support Level N/A N/A
Resistance Level $3.66 $8.64
Average True Range (ATR) 0.32 0.18
MACD -0.00 -0.16
Stochastic Oscillator 1.50 0.14

Price Performance

Historical Comparison
BOXL
GOVX

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions, including flat-panels, LED video walls, and digital signage for the enterprise market. It has three reportable segments - Europe, Middle East and Africa (EMEA), and North and Central America (Americas). The majority of revenue is derived from the sale of education technology products in the EMEA segment.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

Share on Social Networks: